Algernon Pharmaceuticals Inc. (AGNPF)
OTCMKTS · Delayed Price · Currency is USD
0.0475
-0.0004 (-0.84%)
Aug 19, 2025, 1:59 PM EDT
Algernon Pharmaceuticals Market Cap
Algernon Pharmaceuticals has a market cap or net worth of $1.80 million as of August 19, 2025. Its market cap has decreased by -2.21% in one year.
Market Cap
1.80M
Enterprise Value
1.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since February 1, 2016, Algernon Pharmaceuticals's market cap has decreased from 12.66M to 1.80M, a decrease of -85.79%. That is a compound annual growth rate of -18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 1.80M | 35.41% |
| Dec 31, 2024 | 1.33M | 38.32% |
| Dec 29, 2023 | 960.22K | -74.54% |
| Dec 30, 2022 | 3.77M | -30.49% |
| Dec 31, 2021 | 5.43M | -77.97% |
| Dec 31, 2020 | 24.63M | 709.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |